Secondary and unspecified malignant neoplasm of lymph nodes
In Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80), chapter 2: Neoplasms
8 billable codes under C77: all are a CC; all map to HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid), HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic), HCC 20 (Lung and Other Severe Cancers).A CC or MCC (major CC) is a secondary diagnosis that raises the MS-DRG payment. An HCC counts toward a Medicare Advantage patient's risk score.
Advertisements
Instructional notes
Official coding guidelines
From the ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 (CMS and NCHS). Links open the PDF at the right page.
- Section I.C.2.t Secondary malignant neoplasm of lymphoid tissue (page 39), covers C77
When a lymphoid tissue malignancy spreads beyond the lymph nodes, assign a C81 to C85 code for extranodal and solid organ sites instead of a secondary neoplasm code for the affected organ.
Other Chapter 2 topics:
- Admission/Encounter for treatment of primary site (page 33)
- Admission/Encounter for treatment of secondary site (page 33)
- Coding and sequencing of complications (page 34)
- Primary malignancy previously excised (page 34)
- Admissions/Encounters involving antineoplastic chemotherapy, immunotherapy and radiation therapy (page 35)
- Admission/encounter to determine extent of malignancy (page 36)
- Symptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms (page 36)
- Admission/encounter for pain control/management (page 36)
All codes under C77
C77 can't be used on a claim. Pick a billable code below; grey headings group them.
- C77.0Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
- C77.1Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes
- C77.2Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
- C77.3Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes
- C77.4Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes
- C77.5Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
- C77.8Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions
- C77.9Secondary and unspecified malignant neoplasm of lymph node, unspecified
C77 MS-DRGs
As the principal diagnosis, the billable codes under C77 group to these 9 MS-DRGs (v44.0). Which one applies depends on procedures performed, secondary diagnoses (CC/MCC), and the patient's age and discharge status.
- DRG 820 Lymphoma and Leukemia with Major O.R. Procedures with MCC (7 of 8 codes)
- DRG 821 Lymphoma and Leukemia with Major O.R. Procedures with CC (7 of 8 codes)
- DRG 822 Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC (7 of 8 codes)
- DRG 823 Lymphoma and Non-Acute Leukemia with Other Procedures with MCC (7 of 8 codes)
- DRG 824 Lymphoma and Non-Acute Leukemia with Other Procedures with CC (7 of 8 codes)
- DRG 825 Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC (7 of 8 codes)
- DRG 840 Lymphoma and Non-Acute Leukemia with MCC (7 of 8 codes)
- DRG 841 Lymphoma and Non-Acute Leukemia with CC (7 of 8 codes)
- DRG 842 Lymphoma and Non-Acute Leukemia without CC/MCC (7 of 8 codes)
Other codes that refer to C77
Notes on these codes point to C77.
About the condition
Plain-language background from MedlinePlus (National Library of Medicine), not coding guidance.
Cancer
Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor.
Read more about cancer on MedlinePlusCode history
Valid since FY2016, when ICD-10-CM took effect on October 1, 2015. No changes since.
